EMA has recommended granting a conditional marketing authorisation for COVID-19 Vaccine AstraZeneca on 29 January 2021to prevent coronavirus disease 2019 (COVID-19) in people from 18 years of age.

Following this granting, the Germand and French NITAGs have issued recommendations on the use of the COVID-19 Vaccine AstraZeneca, including target population and programmatic issues.

  • NITAG Recommendation
  • Germany
  • France